Browse Catapults

News from the catapult network

News headlines from across the Catapult Network. For comprehensive news updates, please explore our Politics Home webpage or visit individual Catapult websites

Graphic of four images including a microscope, a solar panel, a man examining a samply and a flying drone
Catapult Network
NEWS
Catapulting growth in 2023 and beyond
In the face of many challenges – changing customer desires, cost pressures, supply chain disruption, expected regulatory changes and fierce competition – UK innovation is on the rise. This article showcases how Catapults helped to deliver great results for business and industry in 2023; it summarises our predictions for technology-driven advances in 2024 and the years ahead.
Read more
Cell and Gene Therapy
alt=
News
Braintree Manufacturing Innovation Centre: A case study in GMP transformational change
The Cell and Gene Therapy Catapult’s Braintree Manufacturing Innovation Centre (Braintree MIC) is designed to support cell and gene therapy developers to accelerate the development of their Good Manufacturing Practice (GMP) manufacturing operations for advanced therapies at a clinical and commercial scale. Following a successful inspection by the Medicines and Healthcare products Regulatory Agency (MHRA), Braintree MIC received an MHRA Manufacturers and Importers Authorisation for Investigational Medicinal Products (MIA(IMP)) and associated GMP certificate.
Read more
Cell and Gene Therapy
News
Braintree Manufacturing Innovation Centre: A case study in GMP transformational change
The Cell and Gene Therapy Catapult’s Braintree Manufacturing Innovation Centre (Braintree MIC) is designed to support cell and gene therapy developers to accelerate the development of their Good Manufacturing Practice (GMP) manufacturing operations for advanced therapies at a clinical and commercial scale. Following a successful inspection by the Medicines and Healthcare products Regulatory Agency (MHRA), Braintree MIC received an MHRA Manufacturers and Importers Authorisation for Investigational Medicinal Products (MIA(IMP)) and associated GMP certificate.
Read more
Cell and Gene Therapy
two women wearing safety goggles
News
Cell and Gene Therapy Catapult annual review shows investment in the UK advanced therapy industry returned to growth in 2024
The Cell and Gene Therapy Catapult, an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy industry, has revealed new data highlighting the UK’s potential to become a global leader in the sector. Its 2024 annual review demonstrates how, with coherent and concerted action, the UK can take the lead in harnessing the potential of these therapies to deliver life-changing benefits to patients and economic growth to the nation.
Read more